Goldman Sachs’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1,000K | Buy |
|
|||||
|
2025
Q1 | $726K | Sell |
|
|||||
|
2024
Q4 | $2.78M | Buy |
|
|||||
|
2024
Q3 | $2.33M | Buy |
|
|||||
|
2024
Q2 | $2.53M | Buy |
|
|||||
|
2024
Q1 | $5.23M | Buy |
|
|||||
|
2023
Q4 | $4.44M | Buy |
|
|||||
|
2023
Q3 | $4.48M | Sell |
|
|||||
|
2023
Q2 | $20.7M | Buy |
|
|||||
|
2023
Q1 | $3.51M | Sell |
|
|||||
|
2022
Q4 | $7.86M | Buy |
|
|||||
|
2022
Q3 | $7.33M | Sell |
|
|||||
|
2022
Q2 | $11.2M | Buy |
|
|||||
|
2022
Q1 | $12.2M | Buy |
|
|||||
|
2021
Q4 | $11.9M | Sell |
|
|||||
|
2021
Q3 | $15.3M | Buy |
|
|||||
|
2021
Q2 | $4.48M | Buy |
|
|||||
|
2021
Q1 | $2.25M | Sell |
|
|||||
|
2020
Q4 | $11.6M | Buy |
|
|||||
|
2020
Q3 | $1.05M | Buy |
|
|||||
|
2020
Q2 | $664K | Buy |
|